|
US4897308A
(en)
*
|
1975-06-30 |
1990-01-30 |
L'oreal |
Compositions comprising aqueous dispersions of lipid spheres
|
|
JPS61197513A
(ja)
*
|
1985-02-25 |
1986-09-01 |
Ichimaru Fuarukosu Kk |
主薬物を内包した安定なリポソ−ムの製剤化法
|
|
IL79114A
(en)
*
|
1985-08-07 |
1990-09-17 |
Allergan Pharma |
Method and composition for making liposomes
|
|
JPS63211222A
(ja)
*
|
1987-02-27 |
1988-09-02 |
Terumo Corp |
リポソ−ムの製法
|
|
JPH0610131B2
(ja)
*
|
1987-10-30 |
1994-02-09 |
テルモ株式会社 |
リポソームの製法
|
|
KR940000166B1
(ko)
*
|
1989-11-09 |
1994-01-08 |
니혼다바고 상교오 가부시기가이샤 |
신규 글루코사민 유도체 및 이것을 막 구성성분으로서 함유한 리포솜
|
|
EP0482206A4
(en)
*
|
1990-04-12 |
1992-08-19 |
Japan Tobacco Inc. |
4,6-o-hydroxyphosphorylglucosamine derivative
|
|
US5665379A
(en)
*
|
1990-09-28 |
1997-09-09 |
Pharmacia & Upjohn Aktiebolag |
Lipid particle forming matrix, preparation and use thereof
|
|
SE9200951D0
(sv)
*
|
1992-03-27 |
1992-03-27 |
Kabi Pharmacia Ab |
Pharmaceutical composition containing a defined lipid system
|
|
US6593290B1
(en)
|
1996-11-01 |
2003-07-15 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
US6156728A
(en)
|
1996-11-01 |
2000-12-05 |
Genentech, Inc. |
Treatment of inner ear hair cells
|
|
US6726925B1
(en)
|
1998-06-18 |
2004-04-27 |
Duke University |
Temperature-sensitive liposomal formulation
|
|
AUPP785098A0
(en)
|
1998-12-21 |
1999-01-21 |
Victor Chang Cardiac Research Institute, The |
Treatment of heart disease
|
|
AUPR546801A0
(en)
|
2001-06-05 |
2001-06-28 |
Commonwealth Scientific And Industrial Research Organisation |
Recombinant antibodies
|
|
KR100989647B1
(ko)
|
2001-09-24 |
2010-10-26 |
오레곤 헬스 앤드 사이언스 유니버시티 |
식습관의 변화
|
|
WO2003099320A1
(en)
|
2002-05-24 |
2003-12-04 |
Zensun (Shanghai) Sci-Tech.Ltd |
Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
|
|
AR036316A1
(es)
*
|
2002-08-29 |
2004-08-25 |
Monte Verde S A |
Una composicion farmaceutica de liposomas de tamano pequeno y metodo de preparacion
|
|
CN102558352A
(zh)
|
2003-06-27 |
2012-07-11 |
艾默根佛蒙特有限公司 |
针对表皮生长因子受体的缺失突变体的抗体及其使用
|
|
JP4595319B2
(ja)
*
|
2003-12-03 |
2010-12-08 |
コニカミノルタエムジー株式会社 |
リポソーム用脂質、リポソームおよびそれらの製造方法
|
|
JP2005220034A
(ja)
*
|
2004-02-03 |
2005-08-18 |
Konica Minolta Medical & Graphic Inc |
Ｘ線検査用造影剤の製造方法
|
|
JP4649841B2
(ja)
*
|
2004-02-18 |
2011-03-16 |
コニカミノルタエムジー株式会社 |
リポソーム含有製剤の製造方法、およびリポソーム含有製剤
|
|
EP1951890A4
(en)
|
2005-11-16 |
2009-06-24 |
Ambrx Inc |
PROCESSES AND COMPOSITIONS WITH NON-NATURAL AMINO ACIDS
|
|
US20070213264A1
(en)
|
2005-12-02 |
2007-09-13 |
Mingdong Zhou |
Neuregulin variants and methods of screening and using thereof
|
|
JP5738516B2
(ja)
|
2005-12-30 |
2015-06-24 |
ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド |
心機能改善のためのニューレグリンの徐放
|
|
US8124743B2
(en)
|
2006-06-01 |
2012-02-28 |
President And Fellows Of Harvard College |
Purification of a bivalently active antibody using a non-chromatographic method
|
|
CA2682147C
(en)
|
2007-03-30 |
2017-08-08 |
Ambrx, Inc. |
Modified fgf-21 polypeptides and their uses
|
|
PT2318029T
(pt)
|
2008-07-23 |
2018-01-10 |
Ambrx Inc |
Polipéptidos de g-csf bovino modificados e suas utilizações
|
|
MX2011003272A
(es)
|
2008-09-26 |
2011-04-28 |
Ambrx Inc |
Polipeptidos de eritropoyetina animal modificados y sus usos.
|
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
|
MA34521B1
(fr)
|
2010-08-17 |
2013-09-02 |
Ambrx Inc |
Polypeptides de relaxine modifiés et leurs utilisations
|
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
|
CN102366408B
(zh)
*
|
2011-09-14 |
2013-03-20 |
海南灵康制药有限公司 |
单唾液酸四己糖神经节苷脂钠脂质体注射剂
|
|
WO2013053076A1
(en)
|
2011-10-10 |
2013-04-18 |
Zensun （Shanghai）Science & Technology Limited |
Compositions and methods for treating heart failure
|
|
EP2931291B1
(en)
|
2012-12-11 |
2021-10-20 |
The McLean Hospital Corporation |
Xenon treatment as an adjunct to psychotherapy for psychiatric disorders
|
|
WO2014187881A1
(en)
|
2013-05-21 |
2014-11-27 |
Max-Planck Gesellschaft zur Förderung der Wissenschaften e.V. |
Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy
|
|
RU2015154737A
(ru)
|
2013-05-22 |
2017-06-27 |
Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. |
Пролонгированное высвобождение нейрегулина для лечения сердечной недостаточности
|
|
US10507227B2
(en)
|
2014-04-15 |
2019-12-17 |
The Hospital For Sick Children |
Cationic antimicrobial peptides
|
|
SMT202100388T1
(it)
|
2014-10-24 |
2021-09-14 |
Bristol Myers Squibb Co |
Polipeptidi fgf-21 modificati e loro usi
|
|
JP6866060B2
(ja)
*
|
2014-10-27 |
2021-04-28 |
花王株式会社 |
精製茶抽出物の製造方法
|
|
WO2016135140A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
4-aminoquinazoline derivatives as mth1 inhibitors for the therapy of cancer
|
|
WO2016135139A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
2,3-dihydrocyclopenta[b]quinoline derivatives as mth1 inhibitors for the therapy of cancer
|
|
KR20170138410A
(ko)
|
2015-02-23 |
2017-12-15 |
시걸 테라퓨틱스 에스에이에스 |
비-천연 세마포린 3 및 이의 의학적 용도
|
|
WO2016135138A1
(en)
|
2015-02-23 |
2016-09-01 |
Cemm - Forschungszentrum Für Molekulare Medizin Gmbh |
Oxoquinoline derivatives as mth1 inhibitors for the therapy of cancer
|
|
MX377528B
(es)
|
2015-12-09 |
2025-03-10 |
Univ Wien Med |
Compuestos de platino funcionalizados con monomaleimida para la terapia del cáncer.
|
|
AU2017207867A1
(en)
|
2016-01-15 |
2018-08-09 |
Universität Hamburg |
Flavonoide-type compounds bearing an O-rhamnosyl residue
|
|
ES2957548T3
(es)
|
2016-04-15 |
2024-01-22 |
Univ Oxford Innovation Ltd |
Moduladores del receptor de adenosina para el tratamiento de los trastornos del ritmo circadiano
|
|
CN110637027B
(zh)
|
2017-02-08 |
2024-08-30 |
百时美施贵宝公司 |
包含药代动力学增强子的修饰的松弛素多肽及其用途
|
|
CN111372599A
(zh)
|
2017-07-19 |
2020-07-03 |
奥克兰联合服务有限公司 |
细胞因子调节
|